Abstract
AMYOTROPHIC lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord1,2. Its cause is unknown and it is uniformly fatal, typically within five years3. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade4,5. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar4,6,7. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8,9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O–2 to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders11, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Tandan, R. & Bradley, W. G. Ann. Neurol. 18, 271–280 (1985).
Tandan, R. & Bradley, W. G. Ann. Neurol. 18, 419–431 (1985).
Kurland, L. T. Proc. Staff Meet Mayo Clin. 32, 449–462 (1957).
Mulder, D. W. et al. Neurology 36, 511–517 (1986).
Horton, W. A., Eldridge, R. & Brody, J. A. Neurology 26, 460–464 (1976).
Swerts, L. & Van Den Bergh, R. J. J. genet. Hum. 24, 247–255 (1976).
Huisquinet, H. & Franck, G. Clin. Genet. 18, 109–115 (1980).
Siddique, T. et al. New Engl. J. Med. 324, 1381–1384 (1991).
Siddique, T. et al. Neurology 39, 919–925 (1989).
Fridovich, I. Adv. Enzym. 58, 61–97 (1986).
Olanow, C. W. Ann. Neurol. 32, S2–9 (1992).
Rosen, D. R. et al. Hum. molec. Genet. 1, 547 (1992).
Ott, J. Am. hum. Genet. 28, 528–529 (1976).
Ott, J. Analysis of Human Genetics 203–216 (Johns Hopkins Univ. Press, Baltimore, 1991).
Levanon, D. et al. EMBO J. 77–84 (1985).
Hallewell, R. A. et al. in Superoxide Dismutase in Chemistry, Biology and Medicine (ed. Rotilio, G.) 249–256 (Elsevier, 1986).
Orita, M. et al. Genomics 5, 874–879 (1989).
Dausset, J. et al. Genomics 6, 575–577 (1990).
Beckman, J. S. et al. Proc. natn. Acad. Sci. U.S.A. 87, 1620–1624 (1990).
Imlay, J. A. & Linns, S. Science 240, 1302–1309 (1988).
Philips, J. P. et al. Proc. natn. Acad. Sci. U.S.A. 86, 2761–2765 (1989).
Carlioz, A. & Touati, D. EMBO J. 5, 623–630 (1986).
Farr, S. B., D'Ari, R. & Touati, D. Proc. natn. Acad. Sci. U.S.A. 83, 8268–8272 (1986).
Chang, E. C. et al. J. biol. Chem. 266, 4417–4424 (1991).
Minotti, G. & Aust, S. D. Chem. phys. Lipids 44, 191–208 (1987).
Crapo, J. D. et al. Proc. natn. Acad. Sci. U.S.A. 89, 10405–10409 (1992).
Avraham, K. B. et al. Cell 54, 823–829 (1988).
Yarom, R. et al. J. neurol. Sci. 88, 41–53 (1988).
Avraham, K. B. et al. J. Neurocytol. 20, 208–215 (1991).
Wisnieski, K. et al. Clin. Genet 23, 102–110 (1983).
Ackerman, A. D. et al. New Engl. J. Med. 318, 1666–1669 (1988).
Reynolds, J. F., Wyandt, H. E. & Kelley, T. E. Am. J. hum. Genet. 20, 173–180 (1985).
Hjalmarsson, K. et al. Proc. natn. Acad. Sci. U.S.A. 84, 6340–6344 (1987).
Bewley, G. C. Nucleic Acids Res. 16, 2728 (1988).
Henkle, K. J. et al. Infect. Immun. 59, 2063–2069 (1991).
Perl-Treves, R. et al. Plant molec. Biol. 11, 609–623 (1988).
Bermingham-McDonogh, O. et al. Proc. natn. Acad Sci. U.S.A. 85, 4789–4793 (1988).
Muller, H. in Sixth internat. Congr. Genetics (ed. Jones, D.) 213–255 (Brooklyn Botanic Gardens, Menasha, 1932).
Park, E. & Horvitz, H. R. Genetics 113, 821–852 (1986).
Dryja, T. P. et al. Nature 339, 556–558 (1989).
Herskowitz, I. Nature 329, 219–222 (1987).
Parge, H. E., Hallewell, R. A. & Tainer, J. A. Proc. natn. Acad. Sci. U.S.A. 89, 6109–6113 (1992).
Kitagawa, Y. et al. J. Biochem. 109, 477–485 (1991).
Richardson, J. et al. Proc. natn. Acad. Sci. U.S.A. 72, 1349–1353 (1975).
Creagan, R. et al. Humangenetik 20, 203–209 (1973).
Hendrickson, D. et al. Genomics 8, 736–738 (1990).
Shoulson, I. Ann. N.Y. Acad. Sci. 648, 37–41 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosen, D., Siddique, T., Patterson, D. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59–62 (1993). https://doi.org/10.1038/362059a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/362059a0
Further reading
-
Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders
Neurological Research and Practice (2022)
-
Na+/Ca2+ exchanger isoform 1 takes part to the Ca2+-related prosurvival pathway of SOD1 in primary motor neurons exposed to beta-methylamino-l-alanine
Cell Communication and Signaling (2022)
-
The distribution and function of GDE2, a regulator of spinal motor neuron survival, are disrupted in Amyotrophic Lateral Sclerosis
Acta Neuropathologica Communications (2022)
-
Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration
Translational Neurodegeneration (2022)
-
Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons
Gene Therapy (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
